Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Plos One
|
June 23, 2012
Interaction of protein C inhibitor with the type II transmembrane serine protease enteropeptidase
Thomas A Prohaska, Felix C Wahlmüller, Margareta Furtmüller, et al.
Journal of Clinical Lipidology
|
July 10, 2025
Effect of olezarsen on routinely measured lipase and amylase levels in familial chylomicronemia syndrome
Veronica J Alexander, Thomas A Prohaska, Ewa Karwatowska-Prokopczuk, et al.
Journal of Clinical Lipidology
|
May 10, 2023
APOC3 inhibition with volanesorsen reduces hepatic steatosis in patients with severe hypertriglyceridemia
Thomas A Prohaska, Veronica J Alexander, Ewa Karwatowska-Prokopczuk, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 31, 2018
Massively Parallel Sequencing of Peritoneal and Splenic B Cell Repertoires Highlights Unique Properties of B-1 Cell Antibodies
Thomas A Prohaska, Xuchu Que, Cody J Diehl, et al.
Elife
|
January 20, 2022
Systematic analysis of naturally occurring insertions and deletions that alter transcription factor spacing identifies tolerant and sensitive transcription factor pairs
Zeyang Shen, Rick Z Li, Thomas A Prohaska, et al.
Circulation Research
|
June 18, 2015
B-1b Cells Secrete Atheroprotective IgM and Attenuate Atherosclerosis
Sam M Rosenfeld, Heather M Perry, Ayelet Gonen, et al.
The New England Journal of Medicine
|
April 8, 2024
Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome
Erik S G Stroes, Veronica J Alexander, Ewa Karwatowska-Prokopczuk, et al.
Frontiers in Immunology
|
August 8, 2022
B-1b Cells Have Unique Functional Traits Compared to B-1a Cells at Homeostasis and in Aged Hyperlipidemic Mice With Atherosclerosis
Prasad Srikakulapu, Tanyaporn Pattarabanjird, Aditi Upadhye, et al.
American Heart Journal
|
March 10, 2025
Design and rationale of the CORE-TIMI 72a and CORE2-TIMI 72b trials of olezarsen in patients with severe hypertriglyceridemia
Nicholas A Marston, Brian A Bergmark, Veronica J Alexander, et al.
Journal of Lipid Research
|
December 20, 2014
Circulating microparticles carry oxidation-specific epitopes and are recognized by natural IgM antibodies
Dimitrios Tsiantoulas, Thomas Perkmann, Taras Afonyushkin, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Plos One
|
June 23, 2012
Interaction of protein C inhibitor with the type II transmembrane serine protease enteropeptidase
Thomas A Prohaska, Felix C Wahlmüller, Margareta Furtmüller, et al.
Journal of Clinical Lipidology
|
July 10, 2025
Effect of olezarsen on routinely measured lipase and amylase levels in familial chylomicronemia syndrome
Veronica J Alexander, Thomas A Prohaska, Ewa Karwatowska-Prokopczuk, et al.
Journal of Clinical Lipidology
|
May 10, 2023
APOC3 inhibition with volanesorsen reduces hepatic steatosis in patients with severe hypertriglyceridemia
Thomas A Prohaska, Veronica J Alexander, Ewa Karwatowska-Prokopczuk, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 31, 2018
Massively Parallel Sequencing of Peritoneal and Splenic B Cell Repertoires Highlights Unique Properties of B-1 Cell Antibodies
Thomas A Prohaska, Xuchu Que, Cody J Diehl, et al.
Elife
|
January 20, 2022
Systematic analysis of naturally occurring insertions and deletions that alter transcription factor spacing identifies tolerant and sensitive transcription factor pairs
Zeyang Shen, Rick Z Li, Thomas A Prohaska, et al.
Circulation Research
|
June 18, 2015
B-1b Cells Secrete Atheroprotective IgM and Attenuate Atherosclerosis
Sam M Rosenfeld, Heather M Perry, Ayelet Gonen, et al.
The New England Journal of Medicine
|
April 8, 2024
Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome
Erik S G Stroes, Veronica J Alexander, Ewa Karwatowska-Prokopczuk, et al.
Frontiers in Immunology
|
August 8, 2022
B-1b Cells Have Unique Functional Traits Compared to B-1a Cells at Homeostasis and in Aged Hyperlipidemic Mice With Atherosclerosis
Prasad Srikakulapu, Tanyaporn Pattarabanjird, Aditi Upadhye, et al.
American Heart Journal
|
March 10, 2025
Design and rationale of the CORE-TIMI 72a and CORE2-TIMI 72b trials of olezarsen in patients with severe hypertriglyceridemia
Nicholas A Marston, Brian A Bergmark, Veronica J Alexander, et al.
Journal of Lipid Research
|
December 20, 2014
Circulating microparticles carry oxidation-specific epitopes and are recognized by natural IgM antibodies
Dimitrios Tsiantoulas, Thomas Perkmann, Taras Afonyushkin, et al.
Page
of 2